Chemical Compound
(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)5,6,21,23-Tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)[1]benzofuro[4,5-e]pyrido[1,2-a]benzimidazol-25-yl acetate; 2,7-(Epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, [2S-(2R*,16Z,18E,20R*,21R*,22S*,23S*,24S*,25R*,26S*,27R*,28E)]-; L 105; L 105 (ansamacrolide antibiotic); L 105SV; Rifamycin L 105; Rifamycin L 105SV; Rifaximin; Xifaxan; refaximin
CAS Registry Number
80621-81-4
Primary record
(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)5,6,21,23-Tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)[1]benzofuro[4,5-e]pyrido[1,2-a]benzimidazol-25-yl acetate; 2,7-(Epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, [2S-(2R*,16Z,18E,20R*,21R*,22S*,23S*,24S*,25R*,26S*,27R*,28E)]-; L 105; L 105 (ansamacrolide antibiotic); L 105SV; Rifamycin L 105; Rifamycin L 105SV; Rifaximin; Xifaxan; refaximin
- 库存
- 5,109 克
- 纯度
- 99.5 %
- CAS
- 80621-81-4
化合物标识与属性
- CAS
- 80621-81-4
- PubChem CID
- 6436173
- SMILES
- C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C
- Canonical SMILES
- CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C
名称与同义词
- Rifaximin
- Rifaxidin
- Rifacol
- Xifaxan
- Rifaximine
- Rifaximina
- Rifamycin L 105
- Normix
- Fatroximin
- Rifamixin
- Rifaximinum
- Xifaxsan
- Ritacol
- Rifamycin L 105SV
- Xifaxanta
- Rifaxin
- 80621-81-4
- RedActiv
- rifaximinun
- Rifaximine [French]
- Rifaximinum [Latin]
- Spiraxin
- Targaxan
- Flonorm
- Lumenax
- Lormyx
- Rifaximina [Spanish]
- Rifaxidin;
- duplicate RN
- Normix;
- Rifaximin CRS
- 5-yl acetate
- Rifaximin (Xifaxan)
- Rifaximin [USAN:INN]
- Xifaxan (TN)
- RCIFAX
- Rifaximin (Standard)
- RIFAXIMIN 1G
- RIFAXIMIN 5G
- RefChem:57066
- RIFAXIMIN [INN]
- RIFAXIMIN [JAN]
- RIFAXIMIN [MI]
- Unable to generate value
- RIFAXIMIN [USAN]
- C43H51N3O11
- RIFAXIMIN [VANDF]
- Rifacol;Fatroximin;Xifaxan
- Rifaximin [USAN:INN:BAN]
- D04ITO
- RIFAXIMIN [MART.]
- alpha-0817185
- UNII-L36O5T016N
- L 105SV
- RIFAXIMIN [WHO-DD]
- CHEMBL1617
- L36O5T016N
- L 105 (Ansamacrolide antibiotic)
- L-105
- DTXSID7045998
- CHEBI:75246
- Rifaximin (JAN/USAN/INN)
- SCHEMBL124066
- MFCD00864973
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N
- RIFAXIMIN [EP IMPURITY]
- RIFAXIMIN [ORANGE BOOK]
- DTXCID5025998
- NSC-758957
- RIFAXIMIN [EP MONOGRAPH]
- SCHEMBL29353570
- ERK5-2B06
- GTPL12012
- A07AA11
- BRN 3584528
- D06AX11
- MSK7020
- HMS3715B19
- L 105
- BDBM50347620
- HB2568
- HY-13234R
- MSK7020-100A
- Rifaximin for system suitability CRS
- s1790
- L105
- 28,30,32-undecaen-13-yl acetate
- AKOS015963053
- MSK7020-1000A
- ZINC169621200
- ACN-039933
- AR27732
- C43-H51-N3-O11
- CCG-221129
- CID6436173
- CS-O-02226
- DB01220
- NSC 758957
- CID:6436173
- AC-19112
- AN-36430
- BC208535
- H732
- LS-64147
- Rifaximin 1000 microg/mL in Acetonitrile
- SID:376229669
- AB2000295
- LS-178059
- 4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4-c)rifamycin SV
- FT-0651879
- L/105
- NS00000024
- Rifaximin Solution in Acetonitrile, 100ug/mL
- D02554
- J10371
- Rifaximin =97.0% (by HPLC, total nitrogen)
- Rifaximin Solution in Acetonitrile, 1000ug/mL
- 4-deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin
- AB01209738-01
- AB01209738-03
- AB01209738_04
- 621R814
- A916927
- C042734
- Q416073
- Rifaximin for system suitability CRS (Y0001075)
- D000078262
- B2692-077751
- Rifaximin (bioadhesive/ gastrointestinal extended release)
- (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-25-(Acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione
- (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)furo[2'',3'':7',8']naphtho[1',2':4,5]imidazo[1,2-a]pyridin-25-yl acetate
- (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26S,27S,28E)-5,6,21,23,25 Pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-e)pyrido(1,2-a)benzimidazole-1,15(2H)-dione, 25-acetate
- [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate
- 88747-56-2
- 4-Deoxy-4'-methylpyridol[1',2'-1,2]imidazo[5,4-c]rifamycin SV
- {27,32}]heptatriaconta-1,3,5(35),9,19,21,25(36),26(34),
- 2,7-(Epoxy(1,11,13)pentadecatrienoimino)furo(2'',3'':7',8')naphth(1',2':4,5)imidazo(1,2-a)pyridine-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, ( 2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-
- 2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)BENZOFURO(4,5-E)PYRIDO(1,2-A)BENZIMIDAZOLE-1,15(2H)-DIONE, 25-(ACETYLOXY)-5,6,21,23-TETRAHYDROXY-27-METHOXY-2,4,11,16,20,22,24,26-OCTAMETHYL-, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-
- 2,7-(Epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-e)pyrido(1,2-a)benzimidazole-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, (2S-(2R*,16Z,18E,20R*,21R*,22S*,23S*,24S*,25R*,26S*,27R*,28E))-
- 4-deoxy-4'-methylpyrido[1',2'-1,2]-nu-imidazo[5,4-c]rifamycin SV
- Rifaximin (bioadhesive/ gastrointestinal extended release), Salix Pharmaceuticals
- ((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo(23.10.1.14,7.05,35.026,34.027,32)heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl) acetate
- (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-25-(ACETYLOXY)-5,6,21,23-TETRAHYDROXY-27-METHOXY-2,4,11,16,20,22,24,26-OCTAMETHYL-2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)BENZOFURO(4,5-E)PYRIDO(1,2-A)BENZIMIDAZOLE-1,15(2H)-DIONE
- (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,1
- (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-Tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca(1,11,13)trienoimino)furo(2'',3'':7',8')naphtho(1',2':4,5)imidazo(1,2-a)pyridin-25-yl acetate
- (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)5,6,21,23-Tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)[1]benzofuro[4,5-e]pyrido[1,2-a]benzimidazol-25-yl acetate; 2,7-(Epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, [2S-(2R*,16Z,18E,20R*,21R*,22S*,23S*,24S*,25R*,26S*,27R*,28E)]-; L 105; L 105 (ansamacrolide antibiotic); L 105SV; Rifamycin L 105; Rifamycin L 105SV; Rifaximin; Xifaxan; refaximin
- (7S,11S,12R,13S,14R,15R,16R,17S,18S)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo(23.10.1.1^(4,7).0^(5,35).0^(26,34).0^(27,32))heptatriaconta-1,3,5(35),9,19,21,25(36),26(34),28,30,32-undecaen-13-yl acetate
- (7S,11S,12R,13S,14R,15R,16R,17S,18S)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.1^{4,7}.0^{5,35}.0^{26,34}.0^{27,32}]heptatriaconta-1,3,5(35),9,19,21,25(36),26(34),28,30,32-undecaen-13-yl acetate
- (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.1^{4,7}.0^{5,35}.0^{26,34}.0^
- [(7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate
- 2,7-(Epoxy(1,11,13)pentadecatrienoimino)furo(2'',3'':7',8')naphth(1',2':4,5)imidazo(1,2-a)pyridine-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-
- 2,7-(Epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-
- 2,7-(Epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione,25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-,(2s,16z,18e,20s,21s
- 2,7-(Epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione,25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-,(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-
- 5-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)furo[2'',3'':7',8']naphtho[1',2':4,5]imidazo[1,2-a]pyridin-2